Basic Information
Basic information for SOX9-AS1-221-27aa
Peptide Name SOX9-AS1-221-27aa
Genome Position chr17:72071042-72071042,72081962-72082041[-]
Species Human
Peptide Sequence MGFHVLWLLVEFTQWRTLARGRKRGGR
Peptide Length 27
Unique No (SOX9-AS1-205-27aa,SOX9-AS1-216-27aa,SOX9-AS1-218-27aa,SOX9-AS1-224-27aa,SOX9-AS1-226-27aa,SOX9-AS1-230-27aa,SOX9-AS1-233-27aa,SOX9-AS1-236-27aa,SOX9-AS1-238-27aa)
Grand Average of Hydropathicity -0.3148
Relative Molecular Mass 3740.33
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000234899;SOX9-AS1
Transcript ID/Name ENST00000653391;SOX9-AS1-221
Transcript Length 518
Coding Ability 0.3784
DNA Sequence Corresponding to Peptide ATGGGTTTCCATGTCCTTTGGCTTCTGGTTGAGTTCACTCAGTGGAGAACCCTGGCAAGAGGCAGGAAAAGGGGAGGAAGG
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :